contact     sitemap  
  naseba  
  the group  
  series  
  pressroom  
  investors  
investors
 







making it happen ( last news  |  archive )

NASEBA: POSITIVE EBITDA IN 2009

Sophia Antipolis, June 21st 2010

REALIGNMENT HAS PAID OFF, ENABLING THE GROUP TO RESUME ITS GROWTH AS OF 2010


naseba group shareholders met on June 18th, 2010 for their annual general meeting. All of the resolutions put forward were adopted and the accounts for 2009 were approved.

In 2009 the group's consolidated revenues totalled €6.1m [US$8.48m*], down 40 percent in comparison to 2008 (pro forma excluding Asia (excluding the Indian subcontinent)), a reflection on the unprecedented global economic and financial crisis.

However, naseba proved to be instantly reactive to the needs of the market and realigned its geographical and commercial focus, resulting in a positive EBITDA for the first time since it was listed.

--------

*USD – EUR exchange rate at 0.719, average value over 2009


To read the full press release, visit Euronext.




Health care sector to undergo reforms

The UAE healthcare sector will undergo massive reforms with several initiatives currently under process at the Ministry of Health (MoH).
Some of these initiatives included a revision of drug registration law, a new system to control prescription drugs, the establishment of the Emirates Health Authority and the introduction of smart evaluation certificate.

Speaking on the sidelines of the Healthcare Innovative Summit (InnovHealth) in the capital on Sunday, 
Dr Amin Al Amiri, CEO of Medical 
Practice and Licence at MoH, said the ministry will come out with a revised law on drug registration aimed at coping with the new trends of medicine and new developments in the country, as well as, in response to the demands to give more support for the private sector of the pharmaceutical industry.

To read the full article, please visit Khaleej Times.




Call for change to TB deportation law

The law that requires compulsory deportation of expatriates with tuberculosis is counterproductive and should be changed, a senior health official said yesterday.

Dr Ali al Marzooqi, the director of public health and safety at the Dubai Health Authority (DHA), said fear of deportation causes most expatriates with the disease to “disappear” once they are diagnosed.
Speaking at InnovHealth 2010, a two-day health conference in Abu Dhabi, Dr al Marzooqi also said the private sector should be allowed to treat patients with TB.

To read the full article, please visit The National.




Ministry of Health says changes are needed to overcome challenges to healthcare provision in the Middle East

WAM Abu Dhabi, 25th April 2010 (WAM) - InnovHealth - Middle East Innovations Summit, was officially opened this morning with a ribbon cutting ceremony followed by an opening address by Dr. Salem Al Darmaki, Acting Director General, Ministry of Health - United Arab Emirates - at the Yas Island Rotana Hotel in Abu Dhabi.

The summit, hosted by business information group naseba and endorsed by the Ministry of Health, is the region's most strategic and up-to-date summit, focusing on the latest developments in healthcare solutions, scientific research, medical technology and healthcare services.

To read the full article, please visit Emirates News Agency.




naseba group strengthens ties in GCC with IBCG alliance (press clippings)

Strategic alliance with International Business Consultancy Group confirms naseba’s expansion in GCC.

 Download






Your use of this website constitutes acceptance of the Naseba Group Ltd Policy and Terms & Conditions
© Copyright 2010, naseba & nasebanaru are registered companies under Naseba Group



naseba
history
management team
office locations
careers
clients & partners
the group
B2B summits
tradeshows
professional trainings
virtual naseba
ambition
series
capital raising
CxO strategies
healthcare
hospitality
human services
infrastructure
leadership
telecom & IT
transport & logistics
event calendar
pressroom
news
photo gallery
investors
corporate governance
professional advisors
share price
key figures & documentation
how to invest
making it happen
agenda & contact